Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 12 | 124836304 | intron variant | C/T | snv | 0.38 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.810 | 1.000 | 3 | 2011 | 2017 | |||||||
|
12 | 124777047 | 3 prime UTR variant | C/T | snv | 0.55 |
|
0.800 | 1.000 | 4 | 2010 | 2019 | ||||||||||
|
12 | 124853983 | intron variant | C/T | snv | 0.63 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||||
|
12 | 124799220 | intron variant | C/T | snv | 0.63 |
|
0.800 | 1.000 | 2 | 2012 | 2019 | ||||||||||
|
0.851 | 0.040 | 12 | 124822507 | intron variant | G/A | snv | 0.15 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.040 | 12 | 124822507 | intron variant | G/A | snv | 0.15 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 3 | 2017 | 2019 | |||||||
|
0.851 | 0.040 | 12 | 124822507 | intron variant | G/A | snv | 0.15 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2017 | 2019 | |||||||
|
12 | 124777047 | 3 prime UTR variant | C/T | snv | 0.55 |
|
0.700 | 1.000 | 2 | 2010 | 2013 | ||||||||||
|
1.000 | 0.040 | 12 | 124855901 | intron variant | G/A | snv | 0.47 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
12 | 124799220 | intron variant | C/T | snv | 0.63 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
12 | 124853983 | intron variant | C/T | snv | 0.63 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
12 | 124824136 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
12 | 124824136 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
12 | 124825759 | intron variant | G/A | snv | 3.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
12 | 124825759 | intron variant | G/A | snv | 3.1E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.763 | 0.160 | 12 | 124827879 | intron variant | G/C | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.040 | 12 | 124822507 | intron variant | G/A | snv | 0.15 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 12 | 124831509 | intron variant | A/C | snv | 0.16 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 12 | 124832197 | intron variant | C/T | snv | 0.18 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.160 | 12 | 124851404 | intron variant | C/A | snv | 6.5E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.160 | 12 | 124851404 | intron variant | C/A | snv | 6.5E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
12 | 124795115 | intron variant | C/T | snv | 1.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
12 | 124795115 | intron variant | C/T | snv | 1.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
12 | 124798975 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
12 | 124798975 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 |